These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25363403)

  • 21. Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy.
    Jilani I; Kantarjian H; Gorre M; Cortes J; Ottmann O; Bhalla K; Giles FJ; Albitar M
    Leuk Res; 2008 Apr; 32(4):643-9. PubMed ID: 17900686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
    Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
    Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway.
    Markova B; Albers C; Breitenbuecher F; Melo JV; Brümmendorf TH; Heidel F; Lipka D; Duyster J; Huber C; Fischer T
    Oncogene; 2010 Feb; 29(5):739-51. PubMed ID: 19881535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.
    Ren SY; Bolton E; Mohi MG; Morrione A; Neel BG; Skorski T
    Mol Cell Biol; 2005 Sep; 25(18):8001-8. PubMed ID: 16135792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.
    Oki S; Limnander A; Yao PM; Niki M; Pandolfi PP; Rothman PB
    Cell Cycle; 2005 Feb; 4(2):310-4. PubMed ID: 15655368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
    Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
    Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
    Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
    Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
    Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
    Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
    Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
    Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential molecules implicated in downstream signaling pathways of p185BCR-ABL in Ph+ ALL involve GTPase-activating protein, phospholipase C-gamma 1, and phosphatidylinositol 3'-kinase.
    Gotoh A; Miyazawa K; Ohyashiki K; Toyama K
    Leukemia; 1994 Jan; 8(1):115-20. PubMed ID: 8289476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5' region of Cdk6.
    Kollmann K; Heller G; Ott RG; Scheicher R; Zebedin-Brandl E; Schneckenleithner C; Simma O; Warsch W; Eckelhart E; Hoelbl A; Bilban M; Zöchbauer-Müller S; Malumbres M; Sexl V
    Blood; 2011 Apr; 117(15):4065-75. PubMed ID: 21300982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
    Chu S; McDonald T; Bhatia R
    Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2.
    Gelfanov VM; Burgess GS; Litz-Jackson S; King AJ; Marshall MS; Nakshatri H; Boswell HS
    Blood; 2001 Oct; 98(8):2508-17. PubMed ID: 11588049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCR/ABL activates Rap1 and B-Raf to stimulate the MEK/Erk signaling pathway in hematopoietic cells.
    Mizuchi D; Kurosu T; Kida A; Jin ZH; Jin A; Arai A; Miura O
    Biochem Biophys Res Commun; 2005 Jan; 326(3):645-51. PubMed ID: 15596148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the adaptor protein Lnk in leukemia cells.
    Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
    Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
    Kukoc-Zivojnov N; Puccetti E; Chow KU; Bergmann M; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Boehrer S
    Exp Hematol; 2004 Jul; 32(7):649-56. PubMed ID: 15246161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
    Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.
    Jin ZT; Li K; Li M; Ren ZG; Wang FS; Zhu JY; Leng XS; Yu WD
    Chin Med J (Engl); 2015 Feb; 128(4):545-9. PubMed ID: 25673461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells.
    Yin Y; Sun H; Xu J; Xiao F; Wang H; Yang Y; Ren H; Wu CT; Gao C; Wang L
    Leuk Lymphoma; 2015 Jun; 56(6):1813-20. PubMed ID: 25146433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.